Insufficient scRNA-seq data for expression of LIPF at single-cell level.
Insufficient scRNA-seq data for expression of LIPF at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| stomach | 98% | 1438630.01 | 352 / 359 | 38% | 317.02 | 108 / 286 |
| esophagus | 61% | 3811.36 | 888 / 1445 | 27% | 523.06 | 49 / 183 |
| bladder | 81% | 137.19 | 17 / 21 | 2% | 0.29 | 12 / 504 |
| spleen | 79% | 146.88 | 191 / 241 | 0% | 0 | 0 / 0 |
| liver | 78% | 147.13 | 176 / 226 | 0% | 0 | 0 / 406 |
| pancreas | 73% | 127.50 | 239 / 328 | 3% | 0.64 | 6 / 178 |
| intestine | 59% | 378.52 | 566 / 966 | 13% | 356.23 | 69 / 527 |
| adrenal gland | 71% | 153.22 | 183 / 258 | 0% | 0 | 0 / 230 |
| uterus | 69% | 126.88 | 118 / 170 | 1% | 0.05 | 6 / 459 |
| ovary | 64% | 90.60 | 116 / 180 | 4% | 0.14 | 19 / 430 |
| prostate | 61% | 107.34 | 149 / 245 | 4% | 12.32 | 22 / 502 |
| kidney | 62% | 73.46 | 55 / 89 | 1% | 0.02 | 12 / 901 |
| thymus | 59% | 81.33 | 383 / 653 | 3% | 0.10 | 18 / 605 |
| breast | 49% | 325.79 | 223 / 459 | 2% | 0.37 | 23 / 1118 |
| lung | 43% | 469.79 | 251 / 578 | 7% | 14.85 | 80 / 1155 |
| blood vessel | 43% | 100.36 | 573 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 42% | 269.36 | 509 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 42% | 54.89 | 334 / 803 | 0% | 0 | 0 / 0 |
| skin | 40% | 91.07 | 721 / 1809 | 1% | 0.04 | 4 / 472 |
| heart | 40% | 75.47 | 342 / 861 | 0% | 0 | 0 / 0 |
| brain | 38% | 52.76 | 1005 / 2642 | 2% | 0.17 | 11 / 705 |
| peripheral blood | 37% | 53.76 | 346 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006108 | Biological process | malate metabolic process |
| GO_0006641 | Biological process | triglyceride metabolic process |
| GO_0016042 | Biological process | lipid catabolic process |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0005575 | Cellular component | cellular_component |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0004806 | Molecular function | triglyceride lipase activity |
| GO_0016615 | Molecular function | malate dehydrogenase activity |
| GO_0008289 | Molecular function | lipid binding |
| Gene name | LIPF |
| Protein name | Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3) |
| Synonyms | |
| Description | FUNCTION: Catalyzes the hydrolysis of triacylglycerols to yield free fatty acids, diacylglycerol, monoacylglycerol, and glycerol . Shows a preferential hydrolysis at the sn-3 position of triacylglycerol . . |
| Accessions | ENST00000238983.9 [P07098-1] ENST00000394375.7 [P07098-3] P07098 ENST00000608620.5 [P07098-2] ENST00000355843.2 [P07098-4] |